Literature DB >> 19199035

Cell death during sepsis: integration of disintegration in the inflammatory response to overwhelming infection.

Fabiano Pinheiro da Silva1, Victor Nizet.   

Abstract

Sepsis is a major health problem and a leading cause of death worldwide. In recent years, a crescendo of attention has been directed to the mechanisms of cell death that develop during this disease, since these are viewed as important contributors to the proinflammatory and anti-inflammatory responses associated with poor outcome. Here we discuss mechanisms of cell death evident severe bacterial infection and sepsis including necrosis, apoptosis, pyroptosis, and extracellular trap-associated neutrophil death, with a particular emphasis on lymphocyte apoptosis and its contribution to the immunosuppressed phenotype of late sepsis. Individual bacterial pathogens express virulence factors that modulate cell death pathways and influence the sepsis phenotype. A greater knowledge of cell death pathways in sepsis informs the potential for future therapies designed to ameliorate immune dysfunction in this syndrome.

Entities:  

Mesh:

Year:  2009        PMID: 19199035     DOI: 10.1007/s10495-009-0320-3

Source DB:  PubMed          Journal:  Apoptosis        ISSN: 1360-8185            Impact factor:   4.677


  44 in total

1.  Caveolin-1 protects against sepsis by modulating inflammatory response, alleviating bacterial burden, and suppressing thymocyte apoptosis.

Authors:  Hong Feng; Ling Guo; Zhiqing Song; Haiqing Gao; Dan Wang; Weisi Fu; Jingyan Han; Zhenyu Li; Bin Huang; Xiang-An Li
Journal:  J Biol Chem       Date:  2010-06-09       Impact factor: 5.157

2.  Rho kinases (ROCKs) in sepsis-induced acute lung injury.

Authors:  Ravin Narain
Journal:  J Thorac Dis       Date:  2012-02       Impact factor: 2.895

3.  Antimicrobial cathelicidin peptide LL-37 inhibits the pyroptosis of macrophages and improves the survival of polybacterial septic mice.

Authors:  Zhongshuang Hu; Taisuke Murakami; Kaori Suzuki; Hiroshi Tamura; Johannes Reich; Kyoko Kuwahara-Arai; Toshiaki Iba; Isao Nagaoka
Journal:  Int Immunol       Date:  2016-01-07       Impact factor: 4.823

4.  Ensemble pharmacophore meets ensemble docking: a novel screening strategy for the identification of RIPK1 inhibitors.

Authors:  S M Fayaz; G K Rajanikant
Journal:  J Comput Aided Mol Des       Date:  2014-07-01       Impact factor: 3.686

Review 5.  The pathogenesis of sepsis.

Authors:  Deborah J Stearns-Kurosawa; Marcin F Osuchowski; Catherine Valentine; Shinichiro Kurosawa; Daniel G Remick
Journal:  Annu Rev Pathol       Date:  2011       Impact factor: 23.472

6.  The chitinase-like proteins breast regression protein-39 and YKL-40 regulate hyperoxia-induced acute lung injury.

Authors:  Myung Hyun Sohn; Min-Jong Kang; Hiroshi Matsuura; Vineet Bhandari; Ning-Yuan Chen; Chun Geun Lee; Jack A Elias
Journal:  Am J Respir Crit Care Med       Date:  2010-06-17       Impact factor: 21.405

7.  Analysis of particulate contaminations of infusion solutions in a pediatric intensive care unit.

Authors:  Thomas Jack; Bernadette E Brent; Martin Boehne; Meike Müller; Katherina Sewald; Armin Braun; Armin Wessel; Michael Sasse
Journal:  Intensive Care Med       Date:  2010-02-18       Impact factor: 17.440

8.  Vaccination with an attenuated strain of Francisella novicida prevents T-cell depletion and protects mice infected with the wild-type strain from severe sepsis.

Authors:  Jyotika Sharma; Qun Li; Bibhuti B Mishra; Michelle J Georges; Judy M Teale
Journal:  Infect Immun       Date:  2009-07-27       Impact factor: 3.441

Review 9.  Bench-to-bedside review: Beta-adrenergic modulation in sepsis.

Authors:  Etienne de Montmollin; Jerome Aboab; Arnaud Mansart; Djillali Annane
Journal:  Crit Care       Date:  2009-10-23       Impact factor: 9.097

10.  Growing insights into the potential benefits and risks of activated protein C administration in sepsis: a review of preclinical and clinical studies.

Authors:  Laith Altaweel; Daniel Sweeney; Xizhong Cui; Amisha Barochia; Charles Natanson; Peter Q Eichacker
Journal:  Biologics       Date:  2009-09-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.